Study on Antiviral Therapy for HBeAg-positive Chronic Hepatitis B Patients Aged 1-16 Years
Status:
Not yet recruiting
Trial end date:
2023-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to provide theoretical and real world evidence for the
optimization of antiviral treatment by IFN combined with Nucleosides analog in HBeAg positive
chronic hepatitis B patients aged 1-16 years，so that the functional cure could be achieved in
the greatest extent in pediatric patients